nodes	percent_of_prediction	percent_of_DWPC	metapath
Marimastat—MMP9—urinary bladder cancer	0.584	1	CbGaD
Marimastat—MMP21—renal system—urinary bladder cancer	0.00639	0.0388	CbGeAlD
Marimastat—MMP17—prostate gland—urinary bladder cancer	0.00633	0.0385	CbGeAlD
Marimastat—MMP23B—prostate gland—urinary bladder cancer	0.00579	0.0352	CbGeAlD
Marimastat—MMP16—prostate gland—urinary bladder cancer	0.00557	0.0339	CbGeAlD
Marimastat—MMP26—renal system—urinary bladder cancer	0.00521	0.0316	CbGeAlD
Marimastat—MMP11—prostate gland—urinary bladder cancer	0.00468	0.0284	CbGeAlD
Marimastat—MMP15—prostate gland—urinary bladder cancer	0.00422	0.0257	CbGeAlD
Marimastat—ADAM10—Teniposide—Etoposide—urinary bladder cancer	0.00422	1	CbGdCrCtD
Marimastat—MMP26—female reproductive system—urinary bladder cancer	0.00417	0.0253	CbGeAlD
Marimastat—MMP19—prostate gland—urinary bladder cancer	0.00364	0.0221	CbGeAlD
Marimastat—MMP28—female reproductive system—urinary bladder cancer	0.0033	0.02	CbGeAlD
Marimastat—MMP14—prostate gland—urinary bladder cancer	0.00314	0.0191	CbGeAlD
Marimastat—MMP19—seminal vesicle—urinary bladder cancer	0.00308	0.0187	CbGeAlD
Marimastat—MMP10—urethra—urinary bladder cancer	0.00306	0.0186	CbGeAlD
Marimastat—MMP16—female reproductive system—urinary bladder cancer	0.00304	0.0185	CbGeAlD
Marimastat—ADAM10—epithelium—urinary bladder cancer	0.0029	0.0176	CbGeAlD
Marimastat—MMP7—prostate gland—urinary bladder cancer	0.00283	0.0172	CbGeAlD
Marimastat—ADAM10—renal system—urinary bladder cancer	0.00269	0.0164	CbGeAlD
Marimastat—MMP25—urethra—urinary bladder cancer	0.00261	0.0158	CbGeAlD
Marimastat—MMP11—female reproductive system—urinary bladder cancer	0.00256	0.0155	CbGeAlD
Marimastat—MMP10—female reproductive system—urinary bladder cancer	0.0025	0.0152	CbGeAlD
Marimastat—MMP19—urethra—urinary bladder cancer	0.00243	0.0148	CbGeAlD
Marimastat—MMP3—epithelium—urinary bladder cancer	0.00242	0.0147	CbGeAlD
Marimastat—MMP7—seminal vesicle—urinary bladder cancer	0.00239	0.0145	CbGeAlD
Marimastat—MMP3—smooth muscle tissue—urinary bladder cancer	0.00233	0.0142	CbGeAlD
Marimastat—MMP14—epithelium—urinary bladder cancer	0.00231	0.014	CbGeAlD
Marimastat—MMP15—female reproductive system—urinary bladder cancer	0.00231	0.014	CbGeAlD
Marimastat—MMP10—vagina—urinary bladder cancer	0.00226	0.0137	CbGeAlD
Marimastat—MMP14—smooth muscle tissue—urinary bladder cancer	0.00223	0.0135	CbGeAlD
Marimastat—ADAM10—female reproductive system—urinary bladder cancer	0.00216	0.0131	CbGeAlD
Marimastat—MMP14—renal system—urinary bladder cancer	0.00214	0.013	CbGeAlD
Marimastat—MMP14—urethra—urinary bladder cancer	0.00211	0.0128	CbGeAlD
Marimastat—MMP7—epithelium—urinary bladder cancer	0.00208	0.0126	CbGeAlD
Marimastat—MMP17—lymph node—urinary bladder cancer	0.00202	0.0123	CbGeAlD
Marimastat—MMP19—female reproductive system—urinary bladder cancer	0.00198	0.0121	CbGeAlD
Marimastat—MMP7—renal system—urinary bladder cancer	0.00193	0.0117	CbGeAlD
Marimastat—MMP2—prostate gland—urinary bladder cancer	0.00192	0.0117	CbGeAlD
Marimastat—MMP7—urethra—urinary bladder cancer	0.00189	0.0115	CbGeAlD
Marimastat—MMP23B—lymph node—urinary bladder cancer	0.00185	0.0112	CbGeAlD
Marimastat—MMP1—epithelium—urinary bladder cancer	0.00183	0.0111	CbGeAlD
Marimastat—MMP3—female reproductive system—urinary bladder cancer	0.0018	0.0109	CbGeAlD
Marimastat—MMP19—vagina—urinary bladder cancer	0.0018	0.0109	CbGeAlD
Marimastat—MMP16—lymph node—urinary bladder cancer	0.00178	0.0108	CbGeAlD
Marimastat—MMP1—smooth muscle tissue—urinary bladder cancer	0.00177	0.0107	CbGeAlD
Marimastat—MMP13—vagina—urinary bladder cancer	0.00175	0.0106	CbGeAlD
Marimastat—MMP8—female reproductive system—urinary bladder cancer	0.00175	0.0106	CbGeAlD
Marimastat—MMP14—female reproductive system—urinary bladder cancer	0.00172	0.0104	CbGeAlD
Marimastat—MMP1—renal system—urinary bladder cancer	0.0017	0.0103	CbGeAlD
Marimastat—MMP9—prostate gland—urinary bladder cancer	0.00167	0.0101	CbGeAlD
Marimastat—MMP3—vagina—urinary bladder cancer	0.00163	0.00987	CbGeAlD
Marimastat—MMP2—seminal vesicle—urinary bladder cancer	0.00162	0.00986	CbGeAlD
Marimastat—MMP14—vagina—urinary bladder cancer	0.00155	0.00943	CbGeAlD
Marimastat—MMP7—female reproductive system—urinary bladder cancer	0.00154	0.00938	CbGeAlD
Marimastat—MMP11—lymph node—urinary bladder cancer	0.0015	0.00908	CbGeAlD
Marimastat—MMP2—epithelium—urinary bladder cancer	0.00141	0.00857	CbGeAlD
Marimastat—MMP7—vagina—urinary bladder cancer	0.0014	0.00848	CbGeAlD
Marimastat—MMP1—female reproductive system—urinary bladder cancer	0.00136	0.00827	CbGeAlD
Marimastat—MMP2—smooth muscle tissue—urinary bladder cancer	0.00136	0.00826	CbGeAlD
Marimastat—MMP15—lymph node—urinary bladder cancer	0.00135	0.00819	CbGeAlD
Marimastat—MMP2—renal system—urinary bladder cancer	0.00131	0.00795	CbGeAlD
Marimastat—MMP2—urethra—urinary bladder cancer	0.00129	0.00781	CbGeAlD
Marimastat—MMP25—lymph node—urinary bladder cancer	0.00124	0.00755	CbGeAlD
Marimastat—MMP1—vagina—urinary bladder cancer	0.00123	0.00748	CbGeAlD
Marimastat—MMP9—epithelium—urinary bladder cancer	0.00123	0.00745	CbGeAlD
Marimastat—MMP9—smooth muscle tissue—urinary bladder cancer	0.00118	0.00718	CbGeAlD
Marimastat—MMP19—lymph node—urinary bladder cancer	0.00116	0.00705	CbGeAlD
Marimastat—MMP9—renal system—urinary bladder cancer	0.00114	0.00691	CbGeAlD
Marimastat—MMP2—female reproductive system—urinary bladder cancer	0.00105	0.00636	CbGeAlD
Marimastat—MMP8—lymph node—urinary bladder cancer	0.00102	0.00621	CbGeAlD
Marimastat—MMP14—lymph node—urinary bladder cancer	0.001	0.0061	CbGeAlD
Marimastat—MMP2—vagina—urinary bladder cancer	0.000948	0.00576	CbGeAlD
Marimastat—MMP9—female reproductive system—urinary bladder cancer	0.000911	0.00554	CbGeAlD
Marimastat—MMP2—lymph node—urinary bladder cancer	0.000613	0.00372	CbGeAlD
Marimastat—MMP9—lymph node—urinary bladder cancer	0.000533	0.00324	CbGeAlD
Marimastat—ADAM10—Signaling by EGFR—CDKN1A—urinary bladder cancer	7.84e-05	0.000317	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—CDKN1A—urinary bladder cancer	7.83e-05	0.000316	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR—PTEN—urinary bladder cancer	7.83e-05	0.000316	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—PTEN—urinary bladder cancer	7.81e-05	0.000316	CbGpPWpGaD
Marimastat—MMP9—LPA receptor mediated events—EGFR—urinary bladder cancer	7.79e-05	0.000315	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR in Cancer—CDKN1A—urinary bladder cancer	7.77e-05	0.000314	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR in Cancer—PTEN—urinary bladder cancer	7.76e-05	0.000313	CbGpPWpGaD
Marimastat—MMP9—Validated targets of C-MYC transcriptional activation—EP300—urinary bladder cancer	7.72e-05	0.000312	CbGpPWpGaD
Marimastat—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—urinary bladder cancer	7.65e-05	0.000309	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	7.62e-05	0.000308	CbGpPWpGaD
Marimastat—MMP12—Extracellular matrix organization—MMP9—urinary bladder cancer	7.61e-05	0.000308	CbGpPWpGaD
Marimastat—MMP9—AGE/RAGE pathway—EGFR—urinary bladder cancer	7.6e-05	0.000307	CbGpPWpGaD
Marimastat—MMP1—Metabolism of proteins—IGFBP3—urinary bladder cancer	7.46e-05	0.000301	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—EP300—urinary bladder cancer	7.45e-05	0.000301	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—RHOA—urinary bladder cancer	7.44e-05	0.000301	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—MYC—urinary bladder cancer	7.41e-05	0.000299	CbGpPWpGaD
Marimastat—MMP3—Extracellular matrix organization—MMP9—urinary bladder cancer	7.4e-05	0.000299	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	7.27e-05	0.000294	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR—SRC—urinary bladder cancer	7.26e-05	0.000293	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR in Cancer—SRC—urinary bladder cancer	7.19e-05	0.000291	CbGpPWpGaD
Marimastat—MMP2—Metabolism of proteins—IGFBP3—urinary bladder cancer	7.19e-05	0.000291	CbGpPWpGaD
Marimastat—MMP9—CXCR4-mediated signaling events—SRC—urinary bladder cancer	7.15e-05	0.000289	CbGpPWpGaD
Marimastat—ADAM10—Disease—LIG1—urinary bladder cancer	7.12e-05	0.000288	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—NCOR1—urinary bladder cancer	7.07e-05	0.000285	CbGpPWpGaD
Marimastat—MMP1—TGF-beta Signaling Pathway—MYC—urinary bladder cancer	7.06e-05	0.000285	CbGpPWpGaD
Marimastat—MMP3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	7.05e-05	0.000285	CbGpPWpGaD
Marimastat—MMP2—EPH-Ephrin signaling—HRAS—urinary bladder cancer	7.01e-05	0.000283	CbGpPWpGaD
Marimastat—MMP1—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	6.98e-05	0.000282	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—IFNA2—urinary bladder cancer	6.93e-05	0.00028	CbGpPWpGaD
Marimastat—MMP1—Extracellular matrix organization—CDH1—urinary bladder cancer	6.78e-05	0.000274	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—GLI1—urinary bladder cancer	6.75e-05	0.000273	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—PTGS2—urinary bladder cancer	6.74e-05	0.000272	CbGpPWpGaD
Marimastat—MMP9—Validated targets of C-MYC transcriptional activation—MYC—urinary bladder cancer	6.73e-05	0.000272	CbGpPWpGaD
Marimastat—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—urinary bladder cancer	6.66e-05	0.000269	CbGpPWpGaD
Marimastat—MMP3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	6.66e-05	0.000269	CbGpPWpGaD
Marimastat—MMP2—Extracellular matrix organization—CDH1—urinary bladder cancer	6.54e-05	0.000264	CbGpPWpGaD
Marimastat—MMP9—EPH-Ephrin signaling—SRC—urinary bladder cancer	6.53e-05	0.000264	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—CXCL8—urinary bladder cancer	6.53e-05	0.000264	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR—EGFR—urinary bladder cancer	6.36e-05	0.000257	CbGpPWpGaD
Marimastat—MMP13—Extracellular matrix organization—MMP9—urinary bladder cancer	6.35e-05	0.000257	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—EGFR—urinary bladder cancer	6.35e-05	0.000256	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	6.34e-05	0.000256	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR in Cancer—EGFR—urinary bladder cancer	6.3e-05	0.000255	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—HDAC4—urinary bladder cancer	6.28e-05	0.000254	CbGpPWpGaD
Marimastat—MMP9—LPA receptor mediated events—HRAS—urinary bladder cancer	6.25e-05	0.000253	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—IL2—urinary bladder cancer	6.24e-05	0.000252	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	6.2e-05	0.00025	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—RHOA—urinary bladder cancer	6.17e-05	0.000249	CbGpPWpGaD
Marimastat—MMP7—Extracellular matrix organization—MMP9—urinary bladder cancer	6.14e-05	0.000248	CbGpPWpGaD
Marimastat—MMP9—AP-1 transcription factor network—TP53—urinary bladder cancer	6.09e-05	0.000246	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—CCND1—urinary bladder cancer	6.09e-05	0.000246	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR—KRAS—urinary bladder cancer	6.01e-05	0.000243	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—ERBB2—urinary bladder cancer	5.97e-05	0.000241	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR in Cancer—KRAS—urinary bladder cancer	5.96e-05	0.000241	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	5.85e-05	0.000237	CbGpPWpGaD
Marimastat—MMP1—TGF-beta Signaling Pathway—TP53—urinary bladder cancer	5.79e-05	0.000234	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—NCOR1—urinary bladder cancer	5.79e-05	0.000234	CbGpPWpGaD
Marimastat—ADAM10—Extracellular matrix organization—MMP9—urinary bladder cancer	5.77e-05	0.000233	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—ERBB2—urinary bladder cancer	5.71e-05	0.000231	CbGpPWpGaD
Marimastat—MMP3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	5.66e-05	0.000229	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—CDK4—urinary bladder cancer	5.57e-05	0.000225	CbGpPWpGaD
Marimastat—MMP9—Validated targets of C-MYC transcriptional activation—TP53—urinary bladder cancer	5.53e-05	0.000223	CbGpPWpGaD
Marimastat—ADAM10—Disease—ENO2—urinary bladder cancer	5.43e-05	0.000219	CbGpPWpGaD
Marimastat—MMP2—Direct p53 effectors—TP53—urinary bladder cancer	5.33e-05	0.000215	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—GLI1—urinary bladder cancer	5.26e-05	0.000213	CbGpPWpGaD
Marimastat—MMP1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	5.2e-05	0.00021	CbGpPWpGaD
Marimastat—ADAM10—Disease—RBX1—urinary bladder cancer	5.15e-05	0.000208	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR—HRAS—urinary bladder cancer	5.11e-05	0.000206	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—CDKN1A—urinary bladder cancer	5.11e-05	0.000206	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—PTEN—urinary bladder cancer	5.09e-05	0.000206	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—PPARG—urinary bladder cancer	5.06e-05	0.000205	CbGpPWpGaD
Marimastat—ADAM10—Signaling by EGFR in Cancer—HRAS—urinary bladder cancer	5.06e-05	0.000205	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—RHOA—urinary bladder cancer	5.06e-05	0.000204	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—PLAU—urinary bladder cancer	4.92e-05	0.000199	CbGpPWpGaD
Marimastat—MMP1—Extracellular matrix organization—MMP9—urinary bladder cancer	4.91e-05	0.000198	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—MMP9—urinary bladder cancer	4.9e-05	0.000198	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—MYC—urinary bladder cancer	4.88e-05	0.000197	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—CREBBP—urinary bladder cancer	4.86e-05	0.000197	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—EGFR—urinary bladder cancer	4.77e-05	0.000193	CbGpPWpGaD
Marimastat—MMP2—Extracellular matrix organization—MMP9—urinary bladder cancer	4.73e-05	0.000191	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—SRC—urinary bladder cancer	4.72e-05	0.000191	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—ERBB2—urinary bladder cancer	4.68e-05	0.000189	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—RBX1—urinary bladder cancer	4.63e-05	0.000187	CbGpPWpGaD
Marimastat—ADAM10—Disease—JAG1—urinary bladder cancer	4.61e-05	0.000186	CbGpPWpGaD
Marimastat—MMP9—EPH-Ephrin signaling—HRAS—urinary bladder cancer	4.6e-05	0.000186	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—CDK4—urinary bladder cancer	4.57e-05	0.000185	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—TNF—urinary bladder cancer	4.55e-05	0.000184	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—SRC—urinary bladder cancer	4.51e-05	0.000182	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—RHOA—urinary bladder cancer	4.4e-05	0.000178	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—TSC1—urinary bladder cancer	4.35e-05	0.000176	CbGpPWpGaD
Marimastat—MMP9—Extracellular matrix organization—CDH1—urinary bladder cancer	4.29e-05	0.000173	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—PPARG—urinary bladder cancer	4.15e-05	0.000168	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—JAG1—urinary bladder cancer	4.14e-05	0.000167	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—EGFR—urinary bladder cancer	4.14e-05	0.000167	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—ERBB2—urinary bladder cancer	4.07e-05	0.000165	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—CREBBP—urinary bladder cancer	4.06e-05	0.000164	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—MMP9—urinary bladder cancer	4.02e-05	0.000162	CbGpPWpGaD
Marimastat—MMP9—Spinal Cord Injury—TP53—urinary bladder cancer	4.01e-05	0.000162	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—IGF1—urinary bladder cancer	4.01e-05	0.000162	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—CREBBP—urinary bladder cancer	3.99e-05	0.000161	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—EGFR—urinary bladder cancer	3.96e-05	0.00016	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—KRAS—urinary bladder cancer	3.91e-05	0.000158	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—NCOR1—urinary bladder cancer	3.8e-05	0.000154	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—KRAS—urinary bladder cancer	3.74e-05	0.000151	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—SRC—urinary bladder cancer	3.7e-05	0.00015	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—RHOA—urinary bladder cancer	3.67e-05	0.000148	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—RHOA—urinary bladder cancer	3.61e-05	0.000146	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—RBX1—urinary bladder cancer	3.61e-05	0.000146	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—MMP9—urinary bladder cancer	3.49e-05	0.000141	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—TSC1—urinary bladder cancer	3.39e-05	0.000137	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—HDAC4—urinary bladder cancer	3.38e-05	0.000136	CbGpPWpGaD
Marimastat—ADAM10—Disease—NCOR1—urinary bladder cancer	3.36e-05	0.000136	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—S100B—urinary bladder cancer	3.35e-05	0.000136	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—ERBB2—urinary bladder cancer	3.34e-05	0.000135	CbGpPWpGaD
Marimastat—MMP9—Signaling by SCF-KIT—HRAS—urinary bladder cancer	3.32e-05	0.000134	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—RHOA—urinary bladder cancer	3.32e-05	0.000134	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—EP300—urinary bladder cancer	3.31e-05	0.000134	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—EGFR—urinary bladder cancer	3.24e-05	0.000131	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—JAG1—urinary bladder cancer	3.23e-05	0.00013	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—SRC—urinary bladder cancer	3.22e-05	0.00013	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—RHOA—urinary bladder cancer	3.18e-05	0.000128	CbGpPWpGaD
Marimastat—ADAM10—Axon guidance—HRAS—urinary bladder cancer	3.18e-05	0.000128	CbGpPWpGaD
Marimastat—ADAM10—Disease—ERCC2—urinary bladder cancer	3.16e-05	0.000127	CbGpPWpGaD
Marimastat—MMP1—Metabolism of proteins—IGF1—urinary bladder cancer	3.15e-05	0.000127	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—IL2—urinary bladder cancer	3.08e-05	0.000124	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—ERBB2—urinary bladder cancer	3.07e-05	0.000124	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—KRAS—urinary bladder cancer	3.07e-05	0.000124	CbGpPWpGaD
Marimastat—MMP2—Metabolism of proteins—IGF1—urinary bladder cancer	3.04e-05	0.000123	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—NCOR1—urinary bladder cancer	3.02e-05	0.000122	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—CDK4—urinary bladder cancer	3e-05	0.000121	CbGpPWpGaD
Marimastat—ADAM10—Disease—MTHFR—urinary bladder cancer	2.97e-05	0.00012	CbGpPWpGaD
Marimastat—ADAM10—Disease—TERT—urinary bladder cancer	2.96e-05	0.000119	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—MMP9—urinary bladder cancer	2.87e-05	0.000116	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—GLI1—urinary bladder cancer	2.83e-05	0.000114	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—EGFR—urinary bladder cancer	2.82e-05	0.000114	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—CXCL8—urinary bladder cancer	2.79e-05	0.000113	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—EP300—urinary bladder cancer	2.76e-05	0.000112	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—PPARG—urinary bladder cancer	2.72e-05	0.00011	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—EP300—urinary bladder cancer	2.72e-05	0.00011	CbGpPWpGaD
Marimastat—ADAM10—Disease—FGFR3—urinary bladder cancer	2.71e-05	0.00011	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—TNF—urinary bladder cancer	2.69e-05	0.000109	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—SRC—urinary bladder cancer	2.69e-05	0.000109	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—IL2—urinary bladder cancer	2.67e-05	0.000108	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—KRAS—urinary bladder cancer	2.67e-05	0.000108	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—TERT—urinary bladder cancer	2.66e-05	0.000107	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—SRC—urinary bladder cancer	2.64e-05	0.000107	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—CREBBP—urinary bladder cancer	2.62e-05	0.000106	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—S100B—urinary bladder cancer	2.61e-05	0.000106	CbGpPWpGaD
Marimastat—MMP2—Axon guidance—HRAS—urinary bladder cancer	2.61e-05	0.000105	CbGpPWpGaD
Marimastat—MMP1—Metabolism of proteins—CXCL8—urinary bladder cancer	2.54e-05	0.000102	CbGpPWpGaD
Marimastat—MMP2—Metabolism of proteins—CXCL8—urinary bladder cancer	2.44e-05	9.88e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—FGFR3—urinary bladder cancer	2.44e-05	9.86e-05	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—SRC—urinary bladder cancer	2.43e-05	9.81e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—ESR1—urinary bladder cancer	2.37e-05	9.57e-05	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—RHOA—urinary bladder cancer	2.37e-05	9.56e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—NCOR1—urinary bladder cancer	2.35e-05	9.49e-05	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—EGFR—urinary bladder cancer	2.32e-05	9.35e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—CREBBP—urinary bladder cancer	2.31e-05	9.33e-05	CbGpPWpGaD
Marimastat—ADAM10—Developmental Biology—HRAS—urinary bladder cancer	2.27e-05	9.16e-05	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—KRAS—urinary bladder cancer	2.23e-05	8.99e-05	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—TNF—urinary bladder cancer	2.2e-05	8.91e-05	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—ERBB2—urinary bladder cancer	2.19e-05	8.85e-05	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—KRAS—urinary bladder cancer	2.19e-05	8.84e-05	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—EGFR—urinary bladder cancer	2.13e-05	8.6e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—RHOA—urinary bladder cancer	2.09e-05	8.44e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—CREBBP—urinary bladder cancer	2.08e-05	8.39e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—TERT—urinary bladder cancer	2.07e-05	8.37e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—IGF1—urinary bladder cancer	2.05e-05	8.29e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—EGFR—urinary bladder cancer	2.04e-05	8.24e-05	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—KRAS—urinary bladder cancer	2.01e-05	8.12e-05	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—TP53—urinary bladder cancer	1.98e-05	7.99e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—RBX1—urinary bladder cancer	1.94e-05	7.83e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—ERBB2—urinary bladder cancer	1.93e-05	7.82e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—KRAS—urinary bladder cancer	1.93e-05	7.79e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—FGFR3—urinary bladder cancer	1.9e-05	7.68e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—PTGS2—urinary bladder cancer	1.89e-05	7.64e-05	CbGpPWpGaD
Marimastat—MMP1—Hemostasis—HRAS—urinary bladder cancer	1.89e-05	7.64e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—RHOA—urinary bladder cancer	1.88e-05	7.59e-05	CbGpPWpGaD
Marimastat—MMP2—Developmental Biology—HRAS—urinary bladder cancer	1.86e-05	7.51e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—ESR1—urinary bladder cancer	1.85e-05	7.46e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—TSC1—urinary bladder cancer	1.82e-05	7.37e-05	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—EP300—urinary bladder cancer	1.78e-05	7.2e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—ERBB2—urinary bladder cancer	1.74e-05	7.03e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—JAG1—urinary bladder cancer	1.74e-05	7.01e-05	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—SRC—urinary bladder cancer	1.73e-05	7e-05	CbGpPWpGaD
Marimastat—MMP9—Axon guidance—HRAS—urinary bladder cancer	1.71e-05	6.9e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—CDKN1A—urinary bladder cancer	1.65e-05	6.68e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—PTEN—urinary bladder cancer	1.65e-05	6.67e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—CXCL8—urinary bladder cancer	1.65e-05	6.66e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling by GPCR—HRAS—urinary bladder cancer	1.64e-05	6.62e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—CREBBP—urinary bladder cancer	1.62e-05	6.54e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—IGF1—urinary bladder cancer	1.6e-05	6.45e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—IL2—urinary bladder cancer	1.58e-05	6.37e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—EP300—urinary bladder cancer	1.57e-05	6.36e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—CCND1—urinary bladder cancer	1.54e-05	6.21e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—SRC—urinary bladder cancer	1.53e-05	6.18e-05	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—EGFR—urinary bladder cancer	1.52e-05	6.14e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—MMP9—urinary bladder cancer	1.49e-05	6.03e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.49e-05	6e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—PTEN—urinary bladder cancer	1.48e-05	5.99e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—RHOA—urinary bladder cancer	1.46e-05	5.91e-05	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—TNF—urinary bladder cancer	1.45e-05	5.84e-05	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—KRAS—urinary bladder cancer	1.43e-05	5.8e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—EP300—urinary bladder cancer	1.41e-05	5.71e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—S100B—urinary bladder cancer	1.41e-05	5.68e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—SRC—urinary bladder cancer	1.38e-05	5.56e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—MYC—urinary bladder cancer	1.37e-05	5.54e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—ERBB2—urinary bladder cancer	1.35e-05	5.47e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—EGFR—urinary bladder cancer	1.34e-05	5.42e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—CXCL8—urinary bladder cancer	1.28e-05	5.19e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—KRAS—urinary bladder cancer	1.27e-05	5.12e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—NCOR1—urinary bladder cancer	1.26e-05	5.11e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—MYC—urinary bladder cancer	1.23e-05	4.98e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—IL2—urinary bladder cancer	1.23e-05	4.96e-05	CbGpPWpGaD
Marimastat—MMP9—Developmental Biology—HRAS—urinary bladder cancer	1.22e-05	4.93e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—EGFR—urinary bladder cancer	1.21e-05	4.87e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—CCND1—urinary bladder cancer	1.2e-05	4.84e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—MMP9—urinary bladder cancer	1.16e-05	4.7e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—CDKN1A—urinary bladder cancer	1.16e-05	4.68e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—PTEN—urinary bladder cancer	1.16e-05	4.67e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—KRAS—urinary bladder cancer	1.14e-05	4.6e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—TERT—urinary bladder cancer	1.11e-05	4.5e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—EP300—urinary bladder cancer	1.1e-05	4.45e-05	CbGpPWpGaD
Marimastat—ADAM10—Disease—HRAS—urinary bladder cancer	1.08e-05	4.35e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—SRC—urinary bladder cancer	1.07e-05	4.33e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—FGFR3—urinary bladder cancer	1.02e-05	4.13e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—TP53—urinary bladder cancer	1.01e-05	4.09e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—ESR1—urinary bladder cancer	9.93e-06	4.01e-05	CbGpPWpGaD
Marimastat—MMP3—Signaling Pathways—HRAS—urinary bladder cancer	9.68e-06	3.91e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—MYC—urinary bladder cancer	9.6e-06	3.88e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—EGFR—urinary bladder cancer	9.39e-06	3.79e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—KRAS—urinary bladder cancer	8.87e-06	3.58e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—CREBBP—urinary bladder cancer	8.7e-06	3.52e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—IGF1—urinary bladder cancer	8.59e-06	3.47e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—TP53—urinary bladder cancer	7.89e-06	3.19e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—RHOA—urinary bladder cancer	7.87e-06	3.18e-05	CbGpPWpGaD
Marimastat—ADAM10—Signaling Pathways—HRAS—urinary bladder cancer	7.54e-06	3.05e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—ERBB2—urinary bladder cancer	7.29e-06	2.94e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—CXCL8—urinary bladder cancer	6.91e-06	2.79e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—IL2—urinary bladder cancer	6.6e-06	2.67e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—CCND1—urinary bladder cancer	6.44e-06	2.6e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—CDKN1A—urinary bladder cancer	6.23e-06	2.52e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—PTEN—urinary bladder cancer	6.21e-06	2.51e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—EP300—urinary bladder cancer	5.93e-06	2.39e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—SRC—urinary bladder cancer	5.76e-06	2.33e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—MYC—urinary bladder cancer	5.16e-06	2.09e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—EGFR—urinary bladder cancer	5.05e-06	2.04e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—KRAS—urinary bladder cancer	4.77e-06	1.93e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—TP53—urinary bladder cancer	4.24e-06	1.71e-05	CbGpPWpGaD
Marimastat—MMP9—Signaling Pathways—HRAS—urinary bladder cancer	4.06e-06	1.64e-05	CbGpPWpGaD
